NEW YORK (GenomeWeb) – German T-cell research tools firm Lophius Biosciences today announced an exclusive distribution agreement with BL&H for its T-Track CMV kit in South Korea.

Under the terms of the agreement, BL&H will market and sell the test to transplantation centers. The diagnostic assay combines ELISpot assay technology with T-activation technology to measure cytomegalovirus-specific cell mediated immunity in immunocompromised patients.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.